Medpace general counsel Ewald sells $1.35m in stock

Published 29/07/2025, 23:24
Medpace general counsel Ewald sells $1.35m in stock

Stephen P. Ewald, General Counsel & Corp. Secy. at Medpace Holdings, Inc. (NASDAQ:MEDP), sold 3,000 shares of common stock on July 28, 2025. The shares were sold at a price of $450, for a total transaction value of $1,350,000.

Following the transaction, Ewald directly owns 10,343 shares of Medpace Holdings, Inc.

The sale was executed according to a limit order placed by Ewald during an open window period.

Ewald has agreed to voluntarily disgorge to Medpace Holdings, Inc. all statutory "profits" pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, that resulted from the reported transactions and the purchase of two shares within the past six months.

In other recent news, Medpace reported impressive financial results for the second quarter of 2025, with earnings per share reaching $3.10, surpassing the anticipated $2.98. The company also exceeded revenue forecasts, reporting $603.3 million compared to the expected $538.81 million. Despite these strong results, UBS downgraded Medpace from Neutral to Sell, although it slightly increased its price target to $305.00. Similarly, TD Cowen downgraded Medpace from Hold to Sell, even as it raised its price target to $366.00. UBS maintained a Neutral rating with a $300.00 price target, citing a mixed outlook despite Medpace’s better-than-expected Q2 bookings and sales. Analysts from both firms noted that recent stock surges might be influenced by factors other than fundamental business improvements. These developments reflect a complex investor sentiment surrounding Medpace’s future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.